Chronically elevated COX-2 levels correlate with increased risk for colorectal adenocarcinomas, and the use of chronic nonsteroidal anti-inflammatory drugs and administration of TNFα blocking antibodies have been associated with a decreased risk of developing colorectal cancer [217,218]. This evidence concerns the gene TNF and colorectal cancer.